The distribution of different clinicopathological features such as age, sex, smoking history, tumor stage, and mutation status of oncogenes or tumor-suppressor genes (KRAS, EGFR, TP53, STK11) in different groups was compared and presented as percentage bar plot (Figures 3D–H, Supplementary Figures 3B–D). This evidence concerns the gene KRAS and neoplasm.